Showing results (851-860 of 1,109) with videos related to

Sort By:
Pageof 111
Nature Communications|October 25, 2018
Aberrant activation of non-coding RNA targets of transcriptional elongation complexes contributes to TDP-43 toxicityChia-Yu Chung, Amit Berson, Jason R Kennerdell, et al.
Journal of Translational Medicine|May 21, 2026
An imaging biomarker to detect non-glucogenic shift in brain energy metabolism in Alzheimer's diseaseNarayan Datt Soni, Anshuman Swain, Sunil Kumar Khokhar, et al.
The American Journal of Pathology|May 27, 2004
alpha-internexin is present in the pathological inclusions of neuronal intermediate filament inclusion diseaseNigel J Cairns, Victoria Zhukareva, Kunihiro Uryu, et al.
Prostate Cancer and Prostatic Diseases|April 19, 2017
Reduced prostate cancer risk with green tea and epigallocatechin 3-gallate intake among Hong Kong Chinese menP M Y Lee, C F Ng, Z M Liu, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 17, 2012
TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathwaysAlice S Chen-Plotkin, Travis L Unger, Michael D Gallagher, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 8, 2017
GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau FibrilsGarrett S Gibbons, Rachel A Banks, Bumjin Kim, et al.
Acta Neuropathologica Communications|September 10, 2021
Effects of microglial depletion and TREM2 deficiency on Aβ plaque burden and neuritic plaque tau pathology in 5XFAD miceArgyro Thalia Delizannis, Annelies Nonneman, Wangchen Tsering, et al.
The Lancet Regional Health. Western Pacific|July 30, 2021
Access route selection for percutaneous coronary intervention among Vietnamese patients: Implications for in-hospital costs and outcomesHoa T T Vu, Richard Norman, Ngoc M Pham, et al.
Molecular Neurodegeneration|November 5, 2020
Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer's diseaseGarrett S Gibbons, Soo-Jung Kim, Qihui Wu, et al.
Pageof 111